The pathogenesis of FH is usually associated with mutations in the low-density lipoprotein receptor (LDLR), apolipoprotein B (ApoB) and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes (2, 3). The gene discussed is PCSK9; the disease is familial hyperaldosteronism.